The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.486, issue.7403, pp.346-52, 2012. ,
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, vol.235, issue.4785, pp.177-82, 1987. ,
Humanization of an anti-p185HER2 antibody for human cancer therapy, Proceedings of the National Academy of Sciences of the United States of America, vol.89, issue.10, pp.4285-4294, 1992. ,
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2. The oncologist, vol.13, pp.1114-1123, 2008. ,
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial, Lancet Oncol, 2017. ,
Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation, Biochem Biophys Res Commun, vol.203, issue.3, pp.1589-98, 1994. ,
Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor, Molecular and cellular biology, vol.25, issue.24, pp.11005-11023, 2005. ,
Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3, Molecular and cellular biology, vol.30, issue.23, pp.5456-72, 2010. ,
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy, Breast Cancer Res, vol.15, issue.6, 2013. ,
Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2, Steroids, vol.78, issue.6, pp.559-67, 2013. ,
Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2, Cancer cell, vol.6, issue.3, pp.251-61, 2004. ,
Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis, Oncogene, vol.35, issue.17, pp.2208-2230, 2016. ,
Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes, Cancer Res, vol.71, issue.12, pp.4269-79, 2011. ,
The atypical histone macroH2A1.2 interacts with HER-2 protein in cancer cells, The Journal of biological chemistry, vol.287, issue.27, pp.23171-83, 2012. ,
Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients. Endocrine-related cancer, Epub 2008/05/13, vol.15, pp.745-53, 2008. ,
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer, BMC cancer, vol.12, 2012. ,
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance, Oncogene, vol.34, issue.26, pp.3413-3441, 2015. ,
Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties, Genome biology, vol.14, issue.12, 2013. ,
Model-based analysis of ChIP-Seq (MACS), vol.9, 2008. ,
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome, Nat Genet, vol.39, issue.3, pp.311-319, 2007. ,
Proximity ligation assay to detect and localize the interactions of ERalpha with PI3-K and Src in breast cancer cells and tumor samples, Methods Mol Biol, vol.1204, pp.135-178, 2014. ,
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nature genetics, vol.34, issue.3, pp.267-73, 2003. ,
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, vol.102, issue.43, pp.15545-50, 2005. ,
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor, Cell Rep, vol.3, issue.2, pp.342-351, 2013. ,
Nuclear localization of EGF receptor and its potential new role as a transcription factor, Nature cell biology, vol.3, issue.9, 2001. ,
ErbB3(80 kDa), a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1 promoter to activate cell proliferation but is negatively controlled by p14ARF, Cellular signalling, vol.24, issue.5, 2012. ,
Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2. The Journal of biological chemistry, vol.287, pp.16869-79, 2012. ,
JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin, Nature, vol.461, issue.7265, pp.819-841, 2009. ,
A chromatin-modifying function of JNK during stem cell differentiation, Nat Genet, vol.44, issue.1, pp.94-100, 2012. ,
ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions, Methods, vol.48, issue.3, pp.240-248, 2009. ,
Fast gapped-read alignment with Bowtie 2, Nat Methods, vol.9, issue.4, pp.357-366, 2012. ,
A clustering approach for identification of enriched domains from histone modification ChIP-Seq data, Bioinformatics, vol.25, issue.15, pp.1952-1960, 2009. ,
An integrated encyclopedia of DNA elements in the human genome, Nature, vol.489, issue.7414, pp.57-74, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02187850
SUITE: tools for motif discovery and searching, Nucleic Acids Res, vol.37, pp.202-210, 2009. ,
TopHat: discovering splice junctions with RNA-Seq, Bioinformatics, vol.25, issue.9, pp.1105-1116, 2009. ,
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome biology, vol.15, issue.12, p.25516281, 2014. ,